In this Issue:
Intensive vs standard BP control: SPRINT findings
Effects of intensive BP lowering on cardiovascular and renal outcomes
Spironolactone proves itself in resistant hypertension
Lithium, anticonvulsants and CKD
Empagliflozin slows progression of kidney disease in diabetics
Preventing catheter-associated urinary tract infection
Strategies to prevent contrast-induced nephropathy
Belatacept and long-term outcomes in kidney transplantation
Please login below to download this issue (PDF)